What it does / how it works
A linear alpha-MSH analogue that turns on pigment production. The approved product is a slow implant for EPP, not a 10 mg research-vial tan protocol.
| Class | Linear α-MSH analogue |
| Typical vial | 10 mg |
| Reconstitution | 2 mL BAC per 10 mg |
| Storage after mix | 2–8°C, use within 28 days |
Protocol
| Goal | Dose | How often | How long | Route |
| Approved product only | 16 mg implant | Every 60 days | Ongoing for EPP | Implant |
| Research vial note weeks 1-2 | 0.5-1 mg | Once daily | 1-2 weeks load | SubQ |
| Research vial maintain | 0.5-1 mg | 1-2x weekly | Then as needed | SubQ |
Watch: Do not treat a 10 mg vial as one Scenesse dose.